Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Braeburn Pharmaceuticals
Biotech
Cash-strapped Titan delays Parkinson’s implant program
Titan gets the OK to start stage two in a trial of its ropinirole implant for Parkinson’s—but has to postpone because of financial constraints.
Phil Taylor
Jul 3, 2018 9:20am
Titan, Braeburn end licensing deal for implanted drug for opioid addicts
May 30, 2018 9:00am
Mebias' mu opioids best morphine, Trevena med in preclinical studies
Oct 19, 2017 4:05pm
Tocagen seeks $86M IPO to fund cancer gene therapy trial
Mar 10, 2017 4:24am
Braeburn eyes $150M IPO to launch opioid addiction tech
Jan 4, 2017 4:30am
